Not logged in.png)
Share.png)
SavePhase II study of MEK inhibitor trametinib alone and in combination with AKT inhibitor GSK2141795/uprosertib in patients with metastatic triple negative breast cancer
Prasath, Vishnu; Boutrid, Hinda; Wesolowski, Robert; Abdel-Rasoul, Mahmoud; Timmers, Cynthia; Lustberg, Maryam; Layman, Rachel M.; Macrae, Erin; Mrozek, Ewa; Shapiro, Charles; Glover, Kristyn; Vater, Mark; Budd, G. Thomas; Harris, Lyndsay; Isaacs, Claudine; Dees, Claire; Perou, Charles M.; Johnson, Gary L.; Poklepovic, Andrew; Chen, Helen; Villalona-Calero, Miguel; Carson, William; Stover, Daniel G.; Ramaswamy, Bhuvaneswari Share Save A Randomized Phase II Comparison of Single-Agent Carboplatin versus the Combination of Carboplatin and Everolimus for the Treatment of Advanced Triple Negative Breast CancerPatel, Rima; Fukui, Jami; Klein, Paula; Moshier, Erin; Shapiro, Charles; Goel, Anupama; Fasano, Julie; Shao, Theresa; Bhardwaj, Aarti; Vaccaro, Rita; Joshi, Gargi Atul; Sparano, Joseph; Tiersten, Amy Share Save A Multicenter, Phase I/II Trial of Anastrozole, Palbociclib, Trastuzumab, and Pertuzumab in Hormone Receptor (HR)-Positive, HER2-Positive Metastatic Breast Cancer (ASPIRE)Patel, Rima; Cascetta, Krystal; Klein, Paula; Moshier, Erin; Kwa, Maryann; Fasano, Julie; Goel, Anupama; Accordino, Melissa; Shapiro, Charles; Vaccaro, Rita; Joshi, Gargi Atul; Sparano, Joseph; Tiersten, Amy Share Save Share Save Share Save Share Save Share Save Primary analysis from DS8201-A-U105: A 2-part, open label, phase Ib trial assessing trastuzumab deruxtecan (T-DXd) with nivolumab (nivo) in patients (pts) with HER2-expressing advanced breast cancerHamilton, E. P.; Shapiro, C. L.; Boni, V.; Jimenez, M. Martin; Del Conte, G.; Cortes, J.; Agrawal, L.; Arkenau, H-T.; Tan, A. R.; Debruyne, P. R.; Minchom, A. R.; Rutten, A.; Valdes-Albini, F.; Yu, E.; Suto, F.; Cheng, F-C.; Augustine, B.; Cheng, B.; Barrios, D.; Hurvitz, S. A. Share Save Share Save Share Save Share Save Metastatic breast cancer patient perceptions of somatic tumor genomic testingAdams, Elizabeth J.; Asad, Sarah; Reinbolt, Raquel; Collier, Katharine A.; Abdel-Rasoul, Mahmoud; Gillespie, Susan; Chen, James L.; Cherian, Mathew A.; Noonan, Anne M.; Sardesai, Sagar; VanDeusen, Jeffrey; Wesolowski, Robert; Williams, Nicole; Shapiro, Charles L.; Macrae, Erin R.; Pilarski, Robert; Toland, Amanda E.; Senter, Leigha; Ramaswamy, Bhuvaneswari; Lee, Clara N.; Lustberg, Maryam B.; Stover, Daniel G. Share Save Perceptions of somatic genomic testing in patients with metastatic breast cancer: Psychosocial factors, emotional well-being, and genetic comprehensionAdams, Elizabeth J.; Asad, Sarah; Abdel-Rasoul, Mahmoud; Reinbolt, Raquel E.; Wesolowski, Robert; Tolliver, Kaitlyn; Gillespie, Susan; Collier, Katherine A.; Noonan, Anne; Sardesai, Sargar; VanDeusen, Jeffrey; Williams, Nicole; Shapiro, Charles L.; Macre, Erin R.; Ramaswamy, Bhuvaneswari; Lee, Clara N.; Lustberg, Maryam B.; Stover, Daniel G. Share Save Management of Osteoporosis in Survivors of Adult Cancers With Nonmetastatic Disease: ASCO Clinical Practice GuidelineShapiro, Charles L.; Van Poznak, Catherine; Lacchetti, Christina; Kirshner, Jeffrey; Eastell, Richard; Gagel, Robert; Smith, Sean; Edwards, Beatrice J.; Frank, Elizabeth; Lyman, Gary H.; Smith, Matthew R.; Mhaskar, Rahul; Henderson, Tara; Neuner, Joan Share Save Share Save RETRACTION: Sensitizing Estrogen Receptor-negative Breast Cancer Cells to Tamoxifen with OSU-03012, a Novel Celecoxib-derived Phosphoinositide-dependent Protein Kinase-1/Akt Signaling Inhibitor (Retraction of Vol 7, Pg 800, 2008)Weng, Shu-Chuan; Kashida, Yoko; Kulp, Samuel K.; Wang, Dasheng; Brueggemeier, Robert W.; Shapiro, Charles L.; Chen, Ching-Shih Share Save Share Save RETRACTION: Anti-microRNA-222 (anti-miR-222) and-181B suppresses growth of tamoxifen-resistant xenografts in mouse by targeting TIMP3 protein and modulating mitogenic signal (Retraction of Vol 286, Pg 42292, 2011)Lu, Yuanzhi; Roy, Satavisha; Nuovo, Gerard; Ramaswamy, Bhuvaneswari; Miller, Tyler; Shapiro, Charles; Jacob, Samson T.; Majumder, Sarmila Share Save Randomized placebo-controlled pilot trial of omega 3 fatty acids for prevention of aromatase inhibitor-induced musculoskeletal painLustberg, Maryam B.; Orchard, Tonya S.; Reinbolt, Raquel; Andridge, Rebecca; Pan, Xueliang; Belury, Martha; Cole, Rachel; Logan, Amanda; Layman, Rachel; Ramaswamy, Bhuvaneswari; Wesolowski, Robert; Berger, Michael; Patterson, Elaine; Loprinzi, Charles; Shapiro, Charles L.; Yee, Lisa Share Save 
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}